505 related articles for article (PubMed ID: 7377739)
1. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
[TBL] [Abstract][Full Text] [Related]
2. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
[TBL] [Abstract][Full Text] [Related]
3. Immune function of successfully treated lymphoma patients.
King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
[TBL] [Abstract][Full Text] [Related]
4. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
Libánský J; Lukásová M; Pinosová I
Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
[No Abstract] [Full Text] [Related]
5. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
6. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
Churchill WH; Rocklin RR; Moloney WC; David JR
Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
[No Abstract] [Full Text] [Related]
7. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
Babacan E; Cavdar AO; Arcasoy A
Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
[TBL] [Abstract][Full Text] [Related]
8. Immune deficiency in Hodgkin and non-Hodgkin lymphoma.
El-Haddad SI; El-Ashmawy S; Hassan W; George E; Ali FM; Sharaf MA; Mahfouz M
Biomedicine; 1980 Oct; 32(3):128-33. PubMed ID: 7448322
[TBL] [Abstract][Full Text] [Related]
9. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
Lee YT
Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
[TBL] [Abstract][Full Text] [Related]
10. Studies on delayed hypersensitivity of patients with Hodgkin's disease during remission.
Petrov M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):35-9. PubMed ID: 50967
[TBL] [Abstract][Full Text] [Related]
11. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.
Eltringham JR; Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():107-15. PubMed ID: 4582989
[No Abstract] [Full Text] [Related]
12. Adoptive transfer of cell-mediated immunity to tuberculin using RNA from tuberculin-sensitive subjects.
Han T; Pauly JL; Mittelman A
Immunology; 1975 Jan; 28(1):127-32. PubMed ID: 1116867
[TBL] [Abstract][Full Text] [Related]
13. Immunological profile in patients with non-Hodgkin's lymphomas.
Urasiński I; Fiedorowicz-Fabrycy I; Sochacka-Kuzko B; Wichert K
Arch Immunol Ther Exp (Warsz); 1983; 31(4):467-74. PubMed ID: 6689470
[TBL] [Abstract][Full Text] [Related]
14. [The pathophysiology of malignant lymphoma from the hematological point of view. 3. Changes in peripheral blood lymphocyte count and the recovery of cell-mediated immune function after therapy of T-, B-malignant lymphomas and Hodgkin's disease].
Kinoshita K; Amagasaki T; Momita S; Ikeda S; Ichimaru M; Kamihira S
Nihon Ketsueki Gakkai Zasshi; 1986 Aug; 49(5):1068-80. PubMed ID: 3788434
[No Abstract] [Full Text] [Related]
15. Quantitation of immunocompetence in Hodgkin's disease.
Faguet GB
J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
[TBL] [Abstract][Full Text] [Related]
16. [Research on the prognostic value of immunodeficiency in Hodgkin's disease].
Szász B; Dudea C; Róna L; Kifor I; Borsai G; Zegrean G; Rad L
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):511-20. PubMed ID: 6113670
[No Abstract] [Full Text] [Related]
17. Degrees of impairment of cell-mediated immune reactivity in Hodgkin's disease.
Petrov M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):201-10. PubMed ID: 61913
[No Abstract] [Full Text] [Related]
18. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
19. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
[No Abstract] [Full Text] [Related]
20. [Immunological data in the clinical evaluation of Hodgkin's diseases].
Burchardt K
Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
